The final Bispecific Antibodies (BsAbs) Office Hour brought multidisciplinary providers together to explore how programs are scaling outpatient BsAb delivery, adapting to a changing treatment landscape, and building a sustainable business case.
Objectives:
Cara Harshberger, PharmD, BCOPClinical Pharmacist, PharmacyIvinson Memorial HospitalLaramie, WY
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, FHOPADirector of PharmacyMinnesota Oncology Assistant Professor of PharmacyMayo Clinic School of MedicineSt. Paul, MN
Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP, FAPOClinical Oncology Pharmacy ManagerLevine Cancer Institute, Atrium Cancer Center Charlotte, NC